27 July 2023
27 July 2023
The notion of outsourcing has changed over the years as sponsors are regaining their control with hybrid outsourcing models.
Merck and Moderna have introduced global recruitment in the Phase III trial of V940 and Keytruda in patients with resected melanoma.
At day 15, zuranolone offered an improvement of 50% or more in depressive symptoms in 57% of the subjects.
Intrommune Therapeutics has completed the last patient last visit for its desensitisation candidate INT301.
In the trial, TAK-994 was found to offer a statistically significant rise in daytime wakefulness.
Fresh Tracks will sell its rights to forthcoming event-based milestones and profits on net sales of sofpironium bromide to Botanix SB.
The pan-TRK inhibitor was found to have favourable efficacy and safety in adults.
The Phase I vaccine trial will enrol 180 healthy adults age 40 years and above in Mainland China.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
